is commonly treated with anti-glaucoma medications. Recently, selective laser trabeculoplasty (SLT) has been demonstrated to lower the intraocular pressure (IOP) and medication use in NTG.

Purpose: To compare outcomes of selective laser trabeculoplasty (SLT) with drug therapy for glaucoma patients in a prospective randomized clinical trial. Patients and Methods: Sixty-nine patients ...

patients randomized to selective laser trabeculoplasty (SLT) had a 29% lower rate of glaucoma progression versus eye drop ...

announces another groundbreaking milestone as the first practice in Texas to offer the Voyager Direct Selective Laser Trabeculoplasty (DSLT) system. This state-of-the-art technology represents a ...